Inhaled testing simulator 9141

for the pharmaceutical industrydigital

One of the main factors influencing the amount of inhaled drug available to the patient is the interface between the facemask and the patient. Investigating and defining the effect of a facemask to the product’s DDU and APSD is important for the product development. Two types of apparatus arc available, each providing standardised test methods to quantify the effect of using a facemask on drug delivery from the device under test. 1.Facemask Testing Apparatus (FMA) for MDIs with a Spacer/VHC Device Securing Fixature: Secures the spacer/VHC and its associated facemask into position prior to testing Digital gauge measures the force applied to the face model in N or kg (Range 0-2.5 kg) FMA with example valved holding chamber (VHC) ,Face Model and MDI (face model not included with FMA) Face Model Support accepts three different models : infant, child and adult Handwheel adjusts Device Securing Fixature to accommodate spacer/VHCs of various